If your heartburn came roaring back a week or two after you stopped omeprazole, esomeprazole or another proton pump inhibitor (PPI), it may be rebound, not proof that you need the pill forever. While a PPI is holding acid down, the stomach makes more gastrin, a small peptide hormone that drives acid production. When the drug stops, that extra push can briefly produce more acid than before. The flare is usually temporary, but whether and how to stop a prescribed PPI is a decision to make with your clinician, because some people should stay on it.
How gastrin sets up the rebound
The UniProt record for gastrin describes it as a hormone that stimulates the stomach lining to produce and secrete hydrochloric acid; its best-known form is 17 amino acids long. Normally, acid in the stomach acts as a brake on gastrin release. A 2024 review in the International Journal of Molecular Sciences explains what happens on a PPI: with less acid, the brake weakens, gastrin levels rise, and gastrin’s growth-promoting effect enlarges the population of histamine-releasing cells that tell the stomach to make acid. When the PPI is withdrawn, that expanded system can push acid output above pre-treatment levels. Doctors call this rebound acid hypersecretion.
What the studies show about the flare
The clearest evidence comes from people who had no reflux to begin with. In a 2009 randomized, double-blind trial in Gastroenterology, 120 healthy volunteers took either placebo for 12 weeks or esomeprazole for 8 weeks followed by 4 weeks of placebo. In the 4 weeks after the active drug stopped, 44% of the PPI group reported at least one clinically relevant episode of heartburn, acid regurgitation or indigestion, compared with 15% of the placebo group. Because these participants had no reflux disease, the symptoms could not simply be their old condition returning.
The 2024 review summarizes the timing: in previously symptom-free people, symptoms usually appeared 5 to 14 days after stopping and lasted 4 to 5 days on average, although some started three to four weeks out. After more than a year of PPI use, one study found the extra acid secretion itself lasted more than 8 weeks but less than 26 weeks. The review also notes that people often misread rebound symptoms as their original problem coming back and restart the drug, even when they may not need it.
Who should and should not try stopping
The American Gastroenterological Association’s 2022 clinical practice update on de-prescribing PPIs advises that everyone on a PPI have the reason for it reviewed regularly, and that people without a definite ongoing reason be considered for a trial off the drug. It also lists people who generally should not stop: those with complicated reflux such as a history of severe erosive esophagitis, an esophageal ulcer or a narrowing called a peptic stricture; those with Barrett’s esophagus, eosinophilic esophagitis or idiopathic pulmonary fibrosis; and those at high risk of upper digestive bleeding. The update says patients stopping long-term PPI therapy should be told they may develop temporary upper digestive symptoms from rebound, and that either tapering or stopping outright can be considered.
The evidence on how well stopping works is limited. A 2017 Cochrane review of six trials with 1,758 people with milder reflux found that switching to “on-demand” use cut the number of pills taken but may increase symptoms such as indigestion and regurgitation, with low-quality evidence and too little data on long-term benefits and harms.
Practical steps if you want to come off a PPI
- Ask your prescriber why you are taking it and whether that reason still applies. MedlinePlus advises not to stop prescription omeprazole without talking to your doctor.
- If you use the over-the-counter version, MedlinePlus notes the package course is 14 days, repeated no more often than every 4 months without talking to a doctor. Needing it more often than that is worth a visit.
- Expect that a flare in the first few weeks can be rebound, and agree with your clinician in advance on what to do if it happens.
- Use the habits that reduce reflux anyway. The NIDDK lists losing weight if needed, raising the head of the bed, quitting smoking and changing eating habits, and MedlinePlus’s GERD page suggests finishing dinner 2 to 3 hours before bed.
Symptoms that need a clinician, rebound or not
MedlinePlus says to contact your provider if reflux does not improve with lifestyle changes or medicine, or if you have bleeding, choking, frequent vomiting, hoarseness, loss of appetite, weight loss, trouble or pain with swallowing, or a feeling that food or pills are sticking behind the breastbone. Those signs are not explained by rebound and should not be waited out.
By The Everyday Brief · AI-assisted editorial. Drafted with AI research assistance; claims checked against the linked sources (fetched 2026-10-05 PT). Not medical advice.
Sources
- Reimer C, et al. Proton-pump inhibitor therapy induces acid-related symptoms in healthy volunteers after withdrawal of therapy. Gastroenterology, 2009.
- Namikawa K, Björnsson ES. Rebound acid hypersecretion after withdrawal of long-term proton pump inhibitor (PPI) treatment: are PPIs addictive? International Journal of Molecular Sciences, 2024.
- Targownik LE, Fisher DA, Saini SD. AGA clinical practice update on de-prescribing of proton pump inhibitors: expert review. Gastroenterology, 2022.
- Boghossian TA, et al. Deprescribing versus continuation of chronic proton pump inhibitor use in adults. Cochrane Database of Systematic Reviews, 2017.
- MedlinePlus (U.S. National Library of Medicine): Omeprazole
- MedlinePlus: Gastroesophageal reflux disease
- NIDDK: Treatment for GER and GERD
- UniProt: Gastrin (P01350)